SUBSCRIBE
SUBSCRIBE

Brandon May

Psychedelic “Magic Mushroom” Compound Shows Promise for Depressive Disorder in Small Study
A small Phase II study published Wednesday in the New England Journal of Medicine suggests psilocybin, a psychedelic compound found in “magic mushrooms,” may be an effective treatment for moderate-to-severe major depressive disorder.
April 15, 2021
 · 
3 min read
 · 
Brandon May
CDC approved vaccines for adults to boost the immu
Policy
COVID-19 Infection After Vaccine is Rare But Possible, CDC Says
The U.S. CDC said up to 5,800 people who have been fully vaccinated against coronavirus disease 2019 (COVID-19) have been infected by the novel coronavirus following vaccination.
April 15, 2021
 · 
3 min read
 · 
Brandon May
Business
Tango Enters Lucrative SPAC Merger to Drive Precision Medicine Pipeline
Common stock in the new combined company, Tango Therapeutics, Inc., will soon be listed on Nasdaq under ticker “TNGX.”
April 14, 2021
 · 
3 min read
 · 
Brandon May
Business
Series E Financing Round Brings Leading R&D Cloud Platform’s Valuation to $4 Billion
The new financing brings the company’s total funding to approximately $350 million, placing Benchling even closer to an initial public offering.
April 14, 2021
 · 
2 min read
 · 
Brandon May
James R. Martin/Shutterstock
Business
Mayo Clinic Launches Joint Ventures to Create and Commercialize AI Diagnostic Tools
Mayo Clinic announced Wednesday that it has launched two new tech venture companies designed to harness artificial intelligence (AI) and medical algorithms and create “software as medical devices” that clinicians can use to improve treatment across different diseases.
April 14, 2021
 · 
3 min read
 · 
Brandon May
Courtesy of Getty Images
Business
Lilly Closes Dermira’s Menlo Park Facility, Cutting 163 Jobs in the Process
Eli Lilly and Company is set to cut 163 jobs as it closes its Dermira facility in Menlo Park and sells off the latter company’s sweat drug Qbrexza, which is being snatched up by Journey Medical.
April 13, 2021
 · 
3 min read
 · 
Brandon May
BioCapital
Treovir’s Oncolytic Virus Product Extends Survival in Children With Brain Tumors
Treovir announced positive findings from a Phase I study of G207 in 12 children with recurrent high-grade glioma, a type of tumor that comprises 30% of all tumors found in the brain and central nervous system as well as 80% of all malignant brain tumors.
April 13, 2021
 · 
3 min read
 · 
Brandon May
PictureDesignSwiss / Shutterstock
Business
Biogen and Sage’s Movement Disorder Therapy, SAGE-324 Reduces Tremor Score in Study
Recently announced topline results from a Phase II study show SAGE-324, Sage Therapeutics’ investigational oral neuroactive steroid GABAA receptor positive allosteric modulator, significantly reduced tremor score in adult patients with essential tremor.
April 12, 2021
 · 
3 min read
 · 
Brandon May
Lone Star Bio
Taysha Dishes Out $5.5 Million for Rare Disease Gene Therapy
Taysha Gene Therapies has acquired exclusive global rights to TSHA-120, an intrathecally dosed AAV9 gene therapy designed to treat giant axonal neuropathy.
April 12, 2021
 · 
4 min read
 · 
Brandon May
Business
Celcuity and Pfizer Enter Agreement for Breast Cancer Drug Following Positive Data
Clinical-stage biotech company Celcuity announced Thursday that it had entered into a global licensing agreement with Pfizer to develop and commercialize gedatolisib, the latter company’s first-in-class PI3K/mTOR inhibitor for the treatment of breast cancer.
April 9, 2021
 · 
3 min read
 · 
Brandon May
Business
ValenzaBio Closes Series A Financing Round Worth $70 Million
ValenzaBio plans to use the new financing to advance pipeline programs into autoantibody-mediated diseases, thyroid eye disease, inflammatory disorders and other therapeutic areas.
April 8, 2021
 · 
2 min read
 · 
Brandon May
Drug Development
Molecules from Probiotic-Rich Foods May Combat “Cytokine Storm” in COVID-19
A recent study from Ben-Gurion University of the Negev (BGU) found that isolated molecules from probiotic-rich dairy products could have potential as novel drug candidates for fighting against pathogenic bacteria and treating inflammatory diseases.
April 8, 2021
 · 
3 min read
 · 
Brandon May
Eyesonmilan / Shutterstock
Policy
FDA Extends Supplemental NDA Review Period for Lilly and Incyte’s Atopic Dermatitis Drug
The action data was extended by the agency to provide more time to review new data analyses submitted by Lilly, per information requests made by the FDA.
April 7, 2021
 · 
3 min read
 · 
Brandon May
Smith Collection/Gado/Getty Images
Business
Artios, Novartis Aim to Develop and Discover DDR Targets for Cancer in New Partnership
Artios Pharma Limited has entered into a global research collaboration with Novartis for the purpose of discovering and validating next-generation DDR targets and enhancing Novartis’ radioligand therapies.
April 7, 2021
 · 
3 min read
 · 
Brandon May
Podcast on Race Reveals Deep Divides in the Medical Community on Racial/Ethnic Disparities
Several weeks ago, a podcast published on the Journal of the American Medical Association’s website featured a statement that questioned whether racism exists in medicine, a statement that spurred a barrage of complaints from concerned readers, scientists and even public opinion leaders.
April 6, 2021
 · 
3 min read
 · 
Brandon May
Load More